Photo
June 21, 2019
A U.K. agency pumped the brakes on Illumina’s planned $1.2 billion acquisition of Pacific Biosciences. Photo courtesy of Illumina.
Stories this photo appears in:
UK Agency Asks Illumina and Pacific to Address Its Concerns
Failure of Merging Cos to Comply Would Result In a More In-Depth Analysis
A U.K. competition watchdog said on June 18 that Illumina’s planned $1.2 billion acquisition of Pacific Biosciences raises anti-competitive concerns, at a minimum delaying the deal.
